Literature DB >> 944889

Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States.

F Ikuta, H M Zimmerman.   

Abstract

Entities:  

Mesh：

Year:  1976        PMID： 944889     DOI： 10.1212/wnl.26.6_part_2.26

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  69 in total

Review 1.  Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Authors:  Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 2.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

3.  In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques.

Authors:  Michaela A Seigo; Elias S Sotirchos; Scott Newsome; Aleksandra Babiarz; Christopher Eckstein; E'tona Ford; Jonathan D Oakley; Stephanie B Syc; Teresa C Frohman; John N Ratchford; Laura J Balcer; Elliot M Frohman; Peter A Calabresi; Shiv Saidha
Journal:  J Neurol       Date:  2012-03-15       Impact factor: 4.849

4.  Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis.

Authors:  S Galler; J-P Stellmann; K L Young; D Kutzner; C Heesen; J Fiehler; S Siemonsen
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

5.  Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study.

Authors:  J M Stankiewicz; M Neema; D C Alsop; B C Healy; A Arora; G J Buckle; T Chitnis; C R G Guttmann; D Hackney; R Bakshi
Journal:  J Neurol Sci       Date:  2009-04-15       Impact factor: 3.181

Review 6.  Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies.

Authors:  Rachel C Nolan; Omar Akhand; John-Ross Rizzo; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-06       Impact factor: 3.042

7.  MRI in the investigation of patients with myelopathy thought to be due to multiple sclerosis.

Authors:  A Papadopoulos; A Gouliamos; S Trakadas; A Kalovidouris; P Sgouropoulos; S Gatzonis; L Vlahos
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

Review 8.  Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis.

Authors:  Josefine Britze; Gorm Pihl-Jensen; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2017-05-31       Impact factor: 4.849

9.  Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.

Authors:  Kathleen M Zackowski; Seth A Smith; Daniel S Reich; Eliza Gordon-Lipkin; BettyAnn A Chodkowski; Divya R Sambandan; Michael Shteyman; Amy J Bastian; Peter C van Zijl; Peter A Calabresi
Journal:  Brain       Date:  2009-03-18       Impact factor: 13.501

10.  Focal alteration of the intraretinal layers in neurodegenerative disorders.

Authors:  Shriya Airen; Ce Shi; Zhiping Liu; Bonnie E Levin; Joseph F Signorile; Jianhua Wang; Hong Jiang
Journal:  Ann Eye Sci       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.